• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 U=U 时代,艾滋病毒感染者队列中 HIV-RNA < 200 拷贝/ml 所花费的时间。

Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era.

机构信息

Unit of Infectious Diseases, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME) Institute for Global Health UCL, London, UK.

出版信息

AIDS. 2021 Jun 1;35(7):1103-1112. doi: 10.1097/QAD.0000000000002825.

DOI:10.1097/QAD.0000000000002825
PMID:33534204
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9904439/
Abstract

OBJECTIVE

Zero risk of linked HIV transmission in serodiscordant couples when the HIV-infected partner had viral load less than 200 copies/ml ('U status') was found in observational studies. We aimed at estimating the proportion of time in which 'U status' was maintained and identifying factors associated with the risk of losing it.

DESIGN

Observational cohort study.

METHODS

We included participants in the ICONA cohort who had reached an established 'U status' (viral load ≤200 copies/ml for >6 months) as of December 2010. The outcome was the number of person-days of follow-up (PDFU) above a viral load greater than 200 copies/ml, relative to the total number of PDFU observed. A logistic regression model was used to identify factors independently associated with the risk of losing 'U status'.

RESULTS

Eight thousand, two hundred and forty-one persons living with HIV were included in the analysis who contributed 2 670 888 PDFU. Of these, 1648 (20%) were women, 768 (9%) were people who inject drugs (PWID), and 2066 (25%) were foreign-born. The median of viral load measurements was 9 (IQR: 4-15). Overall, only 3.1% of PDFU were observed when viral load was above 200 copies/ml. The proportion of PDFU with viral load more than 200 copies/ml was higher than average in women (5.3%), unemployed (5.4%), PWID (4.7%), and in people with more than three previous virologic failures (6.3%). These variables were significant predictors of losing 'U status' in the multivariable logistic regression.

CONCLUSION

Our results reinforce the validity of the U=U message in real-world setting. However, we identified subsets of our study population at higher risk of losing the 'U status' for whom additional efforts are needed.

摘要

目的

在观察性研究中发现,当 HIV 感染者的病毒载量低于 200 拷贝/ml(“U 状态”)时,血清学不一致的夫妇之间不存在 HIV 传播的风险。本研究旨在估计“U 状态”持续时间的比例,并确定与失去“U 状态”相关的风险因素。

设计

观察性队列研究。

方法

我们纳入了 ICONA 队列中截至 2010 年 12 月已达到稳定“U 状态”(病毒载量≤200 拷贝/ml 且持续时间>6 个月)的参与者。主要结局是病毒载量超过 200 拷贝/ml 的随访人日数(PDFU)与观察到的总 PDFU 之比。采用逻辑回归模型确定与失去“U 状态”风险相关的独立因素。

结果

共纳入 8241 名 HIV 感染者,共随访 2670888 人日。其中,1648 名(20%)为女性,768 名(9%)为注射吸毒者(PWID),2066 名(25%)为外国出生。病毒载量测量值的中位数为 9(四分位距:4-15)。总体而言,仅 3.1%的 PDFU 时病毒载量>200 拷贝/ml。女性(5.3%)、失业者(5.4%)、PWID(4.7%)和多次病毒学失败(6.3%)者的病毒载量>200 拷贝/ml 的 PDFU 比例高于平均水平。这些变量在多变量逻辑回归中是失去“U 状态”的显著预测因素。

结论

本研究结果进一步证实了 U=U 信息在真实环境中的有效性。然而,我们发现研究人群中有一些亚组更有可能失去“U 状态”,需要对这些人群进行额外的努力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f4e/9904439/db76e64b5258/aids-35-1103-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f4e/9904439/e87f76de5706/aids-35-1103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f4e/9904439/fdd90b77a394/aids-35-1103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f4e/9904439/db76e64b5258/aids-35-1103-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f4e/9904439/e87f76de5706/aids-35-1103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f4e/9904439/fdd90b77a394/aids-35-1103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f4e/9904439/db76e64b5258/aids-35-1103-g003.jpg

相似文献

1
Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era.在 U=U 时代,艾滋病毒感染者队列中 HIV-RNA < 200 拷贝/ml 所花费的时间。
AIDS. 2021 Jun 1;35(7):1103-1112. doi: 10.1097/QAD.0000000000002825.
2
Prevalence and predictive value of intermittent viremia with combination hiv therapy.联合抗逆转录病毒疗法期间间歇性病毒血症的患病率及预测价值
JAMA. 2001 Jul 11;286(2):171-9. doi: 10.1001/jama.286.2.171.
3
Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.坚持基于非核苷类逆转录酶抑制剂的艾滋病治疗及病毒学结果。
Ann Intern Med. 2007 Apr 17;146(8):564-73. doi: 10.7326/0003-4819-146-8-200704170-00007.
4
Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics.实现世界卫生组织90%的目标:波兰抗逆转录病毒治疗的疗效与患者基线临床特征相关。
J Int AIDS Soc. 2017 Jul 17;20(1):21847. doi: 10.7448/IAS.20.1.21847.
5
Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.在一组 HIV 阳性患者中,持续低水平病毒血症后的病毒学失败:12 年观察结果。
Clin Infect Dis. 2013 Nov;57(10):1489-96. doi: 10.1093/cid/cit529. Epub 2013 Aug 14.
6
Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.启动四联抗逆转录病毒疗法的初治1型艾滋病毒感染患者病毒学转归和安全性的预测因素:QUEST GW PROB3005研究
Clin Infect Dis. 2007 Aug 1;45(3):381-90. doi: 10.1086/519428. Epub 2007 Jun 26.
7
Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999-2018).一切都很重要——一种使用 HIV 护理连续体的纵向数据来确定艾滋病毒感染者病毒抑制情况的方法——两项大型、德国、多中心真实队列研究 20 多年(1999-2018 年)的结果。
BMC Public Health. 2021 Jan 22;21(1):200. doi: 10.1186/s12889-020-10088-7.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.血清学异性性伴侣中,当 HIV 阳性一方接受抑制性抗反转录病毒治疗时,无保护性行为与 HIV 传播风险
JAMA. 2016 Jul 12;316(2):171-81. doi: 10.1001/jama.2016.5148.
10
Time above 1500 copies: a viral load measure for assessing transmission risk of HIV-positive patients in care.高于1500拷贝的时间:一种用于评估接受治疗的HIV阳性患者传播风险的病毒载量指标。
AIDS. 2015 May 15;29(8):947-54. doi: 10.1097/QAD.0000000000000640.

引用本文的文献

1
The effectiveness of monetary incentives in improving viral suppression, treatment adherence, and retention in care among the general population of people living with HIV: a systematic review and meta-analysis.货币激励措施在提高艾滋病毒感染者普通人群的病毒抑制、治疗依从性和护理留存率方面的有效性:一项系统评价和荟萃分析。
AIDS Res Ther. 2025 Jun 2;22(1):57. doi: 10.1186/s12981-025-00748-2.
2
Age and Race Disparities in Viral Suppression and the Moderating Effect of Substance Use Among Men Who Have Sex with Men Living with HIV.感染艾滋病毒的男男性行为者中病毒抑制的年龄和种族差异以及物质使用的调节作用
J Behav Health Serv Res. 2025 May 9. doi: 10.1007/s11414-025-09948-0.
3
Time to viral load suppression and its predictors among people living with HIV on antiretroviral therapy in Gebi Resu zone, Afar Region, Ethiopia, 2023.
2023 年,在埃塞俄比亚阿法尔地区盖比雷苏地区接受抗逆转录病毒治疗的艾滋病毒感染者中,病毒载量抑制时间及其预测因素。
Front Public Health. 2024 Oct 28;12:1384787. doi: 10.3389/fpubh.2024.1384787. eCollection 2024.
4
Patterns of Transmitted Drug Resistance Mutations and HIV-1 Subtype Dynamics in ART-Naïve Individuals in Veneto, Italy, from 2017 to 2024.2017 年至 2024 年意大利威尼托地区未经 ART 治疗的个体中传播耐药突变模式和 HIV-1 亚型动态。
Viruses. 2024 Aug 30;16(9):1393. doi: 10.3390/v16091393.
5
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned?艾滋病毒感染者对性传播感染和艾滋病毒的认知:我们应该担忧吗?
Healthcare (Basel). 2024 Feb 6;12(4):417. doi: 10.3390/healthcare12040417.
6
Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens.喀麦隆基于实验室的 HIV-1 获得性耐药监测:替诺福韦-拉米夫定-多替拉韦(TLD)作为二线或三线方案的应用意义。
Viruses. 2023 Aug 2;15(8):1683. doi: 10.3390/v15081683.
7
Correlates of concordance between self-reported and lab-confirmed viral load among Black and Latine men who have sex with men (BLMSM) living with HIV in New York City.纽约市感染艾滋病毒的黑人及拉丁裔男男性行为者(BLMSM)中,自我报告的病毒载量与实验室确认的病毒载量之间的一致性相关因素。
AIDS Care. 2024 May;36(5):661-671. doi: 10.1080/09540121.2023.2229816. Epub 2023 Jul 3.
8
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study.过去 20 年中 HIV 治疗中断的原因:一项多队列真实研究。
Viruses. 2023 Mar 10;15(3):720. doi: 10.3390/v15030720.
9
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project.大学医院中基于HIV感染指示疾病的主动病例发现:SHOT项目的结果。
Infect Dis Rep. 2023 Jan 29;15(1):94-101. doi: 10.3390/idr15010010.
10
Two-drug regimens for HIV treatment.用于艾滋病治疗的两药方案。
Lancet HIV. 2022 Dec;9(12):e868-e883. doi: 10.1016/S2352-3018(22)00249-1. Epub 2022 Oct 26.